Cure SMA has just awarded Ohio State University’s Christine Beattie, Ph.D., a $140,000 basic research funding grant for her project on spinal muscular atrophy (SMA): “Identification of SMN:HuD bound RNAs critical for motor neuron development.” Beattie is a professor in OSU’s Department of Neuroscience. She began studying motor…
This year’s SMA Researcher Meeting received a record number of abstract submissions, totaling 118 contributions from 14 countries, six different companies, and more than 50 institutions worldwide. The Researcher Meeting is expected to attract more than 300 researchers and clinicians from nearly 100 intuitions, plus other attendants, making this year’s meeting an…
Cytokinetics has announced additional details about a planned Phase 2 clinical trial of CK-2127107 in patients with spinal muscular atrophy (SMA). Investigators believe CK-2127107, a skeletal muscle activator, has the potential to improve muscle function, either alone or in combination with other drugs. The company, in collaboration with its partner Astellas, recently held…
Scientists granted initial funding worth $50,000 from Cure SMA recently published a study that found obese children suffering from SMA Type 2 had a higher risk of developing impaired glucose tolerance, regardless of their degree of visual obesity. The lead investigators of the study, “Responses to Fasting and Glucose Loading…
Cure SMA, one of the country’s leading not-for-profit organizations committed to find a cure for spinal muscular atrophy and improve the lives of those afflicted by the disease, has been conducting its series of SMA Researcher Meetings which began earlier this year in June and will end in December. The organization regularly updates its…
Studies conducted on mouse models of spinal muscular atrophy (SMA) have led scientists to believe that it is imperative to receive treatment as early as possible, even as soon as the child is born. Knowing this, the SMA research community has begun working on ways to establish newborn screening (NBS)…
Cure SMA, an organization committed to fund and direct comprehensive research that drives breakthroughs in treatment and care for SMA patients, has just announced plans to award $1.995 million worth of research grants for the upcoming months. These grants cover all 4 focused areas of Cure SMA’s research model: basic research, drug…
A 10-year-old child born with spinal muscular atrophy is throwing a benefit concert in support of everyone living with this rare, genetic disease that causes progressive muscle wasting and mobility impairment. While SMA has been known to be fatal in infants, oftentimes causing death by the second year of life, Adyn Bucher…
